达克罗宁复合丙泊酚用于无痛胃镜检查的临床效果

发布时间：2018-05-04 06:41

本文选题：无痛胃镜 + 丙泊酚　；参考：《实用医学杂志》2017年17期

【摘要】：目的探讨达克罗宁复合丙泊酚用于无痛胃镜检查中的安全性和可行性。方法选择2016年9-12月在我院行无痛胃镜检查的90例患者,按随机数字表法分为3组:达克罗宁+丙泊酚组(DP组)、芬太尼+丙泊酚组(FP组)、丙泊酚组(P组),每组各30例。观察并记录3组患者检查前、中、后的血流动力学变化,不良反应,丙泊酚用量,检查及苏醒时间。结果 DP组与FP组在高血压、心动过速、呛咳、体动的发生率,以及丙泊酚用量显著低于P组(P0.05),FP组和P组在呼吸抑制发生率、检查及苏醒时间显著高于DP组(P0.01),DP组和P组在恶心呕吐发生率显著低于FP组(P0.05)。结论达克罗宁复合丙泊酚用于无痛胃镜检查,降低了检查时心血管反应、呛咳、体动、呼吸抑制、恶心呕吐等不良反应的发生率,减少了丙泊酚用量,缩短了检查和苏醒时间。因此,达克罗宁复合丙泊酚用于无痛胃镜检查是一种更加安全可行的麻醉方案。
[Abstract]:Objective to investigate the safety and feasibility of dacronin combined with propofol in painless gastroscopy. Methods 90 patients undergoing painless gastroscopy in our hospital from September to December 2016 were randomly divided into 3 groups: Dacronin propofol group (DP group), fentanyl propofol group (FP group) and propofol group (P group) (30 cases in each group). Hemodynamic changes, adverse reactions, propofol dosage, examination and recovery time were observed and recorded before, during and after examination. Results the incidence of hypertension, tachycardia, cough, body movement and propofol consumption in DP group and FP group were significantly lower than those in P group P 0.05 group and P group P group. The time of examination and recovery was significantly higher in DP group than that in DP group (P 0.01) and P group P group (P < 0.01). The incidence of nausea and vomiting in P group was significantly lower than that in FP group (P 0.05). Conclusion Dacronin combined with propofol for painless gastroscopy can reduce the incidence of adverse reactions such as cardiovascular reaction, cough, body movement, respiratory depression, nausea and vomiting, reduce the dosage of propofol, and shorten the time of examination and recovery. Therefore, dacronin combined with propofol for painless gastroscopy is a more safe and feasible anesthetic scheme.
【作者单位】：广东省深圳市龙岗区第三人民医院麻醉科;中山大学孙逸仙纪念医院麻醉科;
【分类号】：R614

【相似文献】